Transition zone index and bothersomeness of voiding symptoms as predictors of early unfavorable outcomes after transurethral resection of prostate

Urologia Internationalis

Volumn 81, Issue 4, 2008, Pages 421-426

  Milonas, Daimantas ^a,b   Saferis, Viktoras ^a   Jievaltas, Mindaugas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

Author keywords

Benign prostatic hyperplasia; Transition zone index; Transurethral resection of prostate

Indexed keywords

ADULT; AGED; ARTICLE; BOTHERSOMENESS; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; REGRESSION ANALYSIS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINATION;

EID: 57649139262     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167840     Document Type: Article

References (18)

1. Tubaro A, Vicenti C, Renzetti R, Miano L: Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomized controlled trials? Eur Urol Suppl 2000;38:7-17.
2. Clifford GM, Farmer RDT: Medical therapy for benign prostatic hyperplasia: a review of the literature. Eur Urol 1999;38:2-19.
3. Kaplan SA, Bowers DL, Te AE: Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J Urol 1996;155:1305-1310.
4. Hakenberg OW, Pinnock CB, Marshall VR: The follow-up of patients with unfavourable early results of transurethral prostatectomy. BJU Int 1999;84:799-804.
5. Bergdahl S, Aus G, Hugosson J, Norlen L, Lodding P: Transrectal ultrasound with separate measurement of the transition zone volume predicts the short-term outcome after transurethral resection of the prostate. Urology 1999;53:926-930.
6. Otani T, Hayashi Y, Kishino TE, Fujimoto K, Hirao Y, Orano S, Okajima E: A new parameter in decision making for transurethral electroresection of benign prostate hyperplasia. Eur Urol 1999;35:185-191.
7. Aso Y, Boccon-Gibob L, Brendler CB, et al: Clinical research criteria. Proc 2nd Int Consultation Benign Prostatic Hyperplasia, Paris, 1993, pp 343-360.
8. Aso Y, Homma Y: Clinical research criteria: response criteria for evaluating efficacy of treatments for benign prostatic hyperplasia. Br J Urol 1995;76(suppl 1):69-73.
9. Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T: The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy. J Urol 1994;152:443-447.
10. Hakenberg OW, Pinnock CB, Marshall VR: Does evaluation with International Prostate Symptom Score predict the outcome of transurethral resection of the prostate? J Urol 1997;158:94-99.
11. Walden M, Dahstrand C, Shafer W: How to select patients suitable for transurethral microwave thermotherapy: a systematic evaluation of potentially predictive variables. Br J Urol 1998;81:817-821.
12. Kuo HC, Chang SC, Hsu T: Predictive factors for successful surgical outcome of benign prostatic hypertrophy. Eur Urol 1993;24:12-19.
13. Milonas D, Trumbeckas D: Prostate-specific antigen and transition zone index - powerful predictors of acute urinary retention in men with benign prostatic hyperplasia. Medicina 2003;39:1071-1077.
14. Marberger MJ, Andersen JT, Nickel JC, Malice MP, Gabriel M, Pappas F, Meehan A, Stoner E, Waldstreicher J: Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Eur Urol 2000;38:563-568.
15. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, Castellanos R, Coffield S, Saltzman B, Resnick M, Cook TJ, Waldstreicher J: Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology 1999;53:473-480.
16. Kaplan SA, Te AE, Pressler LB, Olson CA: Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol 1995;154:1764-1769.
17. de la Rosette JJ, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, de Wildt M: EAU guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2001;40:256-263.
18. Hunter DJW, McKee M, Black NA, Sanderson CFB: Health status and quality of life of British men with lower urinary tract symptoms: results from the SF 36. Urology 1995;45:962-971.